Castlight Health (CSLT) Tops Q1 EPS by 2c

Castlight Health (NYSE: CSLT) reported Q1 EPS of $0.01, $0.02 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $35.1 million versus the consensus estimate of $34.73 million.

"We executed well in the first quarter and made meaningful progress against each of our three priorities for 2021 while delivering strong financial results, including sequential ARR growth and our fourth straight quarter of non-GAAP profitability," said Maeve O\'Meara, chief executive officer of Castlight Health. "We were pleased with our pipeline generation activity in the quarter, reported our lowest churn quarter since 2016, and expanded a key health plan partnership. We demonstrated our commitment and ability to innovate in the category of next generation navigation with the launch of our market-leading vaccine navigation solution. Finally, we expanded and extended our work with Boston Children\'s Hospital to support the nation's ongoing COVID-19 vaccination effort. Our progress in the first quarter allows us to increase our financial guidance for 2021."

GUIDANCE:

Castlight Health sees Q2 2021 EPS of ($0.03)-$0.01. Castlight Health sees Q2 2021 revenue of $135-140 million, versus the consensus of $132.68 million.

For earnings history and earnings-related data on Castlight Health (CSLT) click here.

You May Also Be Interested In

• IBM plunges 19% as memory capex squeeze derails Q2 earnings
• Tower Semiconductor, CleanSpark surge premarket; IBM, JPMorgan slip
• UBS Reiterates Buy Rating on Boot Barn (BOOT), Expects Q1 Earnings Beat